Vanderbilt University Medical Center is one of two facilities in Tennessee recognized by Becker’s Hospital Review as “hospitals and health systems with great oncology programs” for 2025. 

“Vanderbilt-Ingram Cancer Center, part of Vanderbilt University Medical Center, is the only NCI-designated comprehensive cancer center in Tennessee that provides care for both adults and children,” Becker’s Hospital Review noted. “Recognized by U.S. News & World Report as a top-performing cancer hospital, Vanderbilt-Ingram serves more than 49,000 distinct patients and manages over 250,000 outpatient visits annually. With a team of more than 200 cancer specialists and over 300 physician-scientists, the center leads in precision medicine and translational research, supported by more than $150 million in total research funding, including $69 million in competitive NCI grants.

“Vanderbilt-Ingram offers access to more than 350 clinical trials and is the developer of MyCancerGenome.org, a globally recognized resource for genetically informed cancer care. As a member of the National Comprehensive Cancer Network, Vanderbilt-Ingram helps shape national standards in cancer prevention, treatment and survivorship care.” 

The other Tennessee hospital that made the list is Memphis-based St. Jude Children’s Research Hospital. 

The post Becker’s Hospital Review recognizes VUMC as a top oncology provider   appeared first on VUMC News.